Page last updated: 2024-10-21

4-aminopyridine and Convulsions, Febrile

4-aminopyridine has been researched along with Convulsions, Febrile in 1 studies

Research Excerpts

ExcerptRelevanceReference
" AR-R 15896AR prevented tonic seizures in rodents for up to 6 to 8 h in response to maximal electroshock (MES), 4-aminopyridine, bicuculline, or strychnine, as well as characteristic seizures following injections of N-methyl-DL-aspartic or kainic acids."3.70[S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties. ( Balestra, M; Borrelli, AR; Cramer, CL; Eismann, MS; Freedman, LR; Hudzik, TJ; Knowles, MK; Mahmood, N; McCarthy, DJ; Murray, RJ; Palmer, GC; Stagnitto, ML, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palmer, GC1
Murray, RJ1
Cramer, CL1
Stagnitto, ML1
Knowles, MK1
Freedman, LR1
Eismann, MS1
Mahmood, N1
Balestra, M1
Borrelli, AR1
Hudzik, TJ1
McCarthy, DJ1

Other Studies

1 other study available for 4-aminopyridine and Convulsions, Febrile

ArticleYear
[S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:1

    Topics: 4-Aminopyridine; Animals; Anticonvulsants; Bicuculline; Electric Stimulation; Kainic Acid; Male; Mic

1999